Last updated: 2026-09-16 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Microbot Medical, Inc. (MBOT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1,45, with a market capitalisation of $97,39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,42 to $3,74. This page covers its latest market performance, valuation, price trends and company information.
$97,39M | |
$1,45 | |
$192,03 | |
$0,82 | |
$1,44 | |
415,00 | |
677,71K | |
-- | |
$3,74 | |
$1,42 | |
-- | |
-- |
Microbot Medical, Inc. (MBOT) is trading at $1,45 in pre-market trading as of 2026-09-16 10:22:00, up 0,69% ($0,01) from the previous close of $1,44
Pre-market trading shows how investors are pricing MBOT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Microbot Medical, Inc. (MBOT) moved from $1,44 to $1,45, representing a gain of 0,69% ($0,01).
The stock traded between $1,42 and $1,52 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 380,37 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1,3%
MBOT is currently trading at $1,45, placing it 1,3% of the way from its 52-week low of $1,42 to its 52-week high of $3,74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Microbot Medical, Inc. (MBOT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.